• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Puma Biotech Initiates ALISCA™-Breast1 Phase II Trial of Alisertib

    BUSINESSWIRE

    Puma`s Alisertib Phase 1/1b Data In Advanced EGFR-Mutant Lung Cancer

    BUSINESSWIRE

    Puma`s Alisertib Shows Findings In Endocrine-Resistant Metastatic Breast Cancer

    BUSINESSWIRE

    Puma Alisertib Asco Abstracts: 2024 Annual Meeting Titles Published

    BUSINESSWIRE

    Puma Announces FDA Allowance to Proceed Under IND for Alisertib in Breast Cancer

    BUSINESSWIRE

    Puma Bio Announces Initiation of ALISCA-Lung1 Phase II Trial of Alisertib

    BUSINESSWIRE

    Puma Biotechnology Announces Phase II Clinical Trial Design for Alisertib

    BUSINESSWIRE

    Puma Announces Presentation of Findings from a Phase I/II Study of Alisertib

    BUSINESSWIRE

    Puma Biotechnology Receives FDA Orphan Drug Designation for Alisertib

    BUSINESSWIRE

    Puma Announces Presentation of Biomarker Findings from PII Study of Alisertib

    BUSINESSWIRE

    Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.